Ferriprox (deferiprone))

pCPA File Number: 22202

Negotiation Status:

Under consideration for negotiation

Indication(s):

For the treatment of patients with transfusional iron overload due to sickle cell disease or other anemias

Sponsor/Manufacturer:

Chiesi Canada Corporation

CADTH Project Number:

SR0741

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable